Finance

Beta
Lists
AIM:NYSEAMERICAN
AIM ImmunoTech Inc
$0.83
-7.78%
(-0.070) 1D
$0.70
-14.72% (-0.12)
Pre-market
Closed: Jun 2, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AIM...
Open
$0.80
High
$0.85
Low
$0.63
Mkt. cap
19.83M
Avg. vol.
49.59M
Volume
897.86K
52-wk high
$20.33
52-wk low
$0.21
EPS
-$7.39
Beta
1.18
Shares outstanding
14.56M
No. of employees
20
Open
$0.80
High
$0.85
Low
$0.63
Mkt. cap
19.83M
Avg. vol.
49.59M
Volume
897.86K
52-wk high
$20.33
52-wk low
$0.21
EPS
-$7.39
Beta
1.18
Shares outstanding
14.56M
No. of employees
20
News stories
From sources across the web
Profile
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
About AIM ImmunoTech Inc
CEO-
Employees20
Founded1966
HeadquartersPhiladelphia, Pennsylvania, United States
SectorBiotechnology
Websiteaimimmuno.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
25.00K
26.00K
21.00K
22.00K
Cost of goods sold
10.00K
68.00K
40.00K
4.00K
Cost of revenue
10.00K
68.00K
40.00K
4.00K
Research and development expenses
1.17M
607.00K
999.00K
482.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.49M
1.80M
1.93M
1.76M
Operating expense
2.66M
2.40M
2.93M
2.24M
Total operating expenses
2.67M
2.47M
2.97M
2.25M
Operating income
-2.65M
-2.45M
-2.95M
-2.23M
Other non operating income
-
-3.74M
-942.00K
-804.00K
EBT including unusual items
-2.79M
-3.28M
-4.18M
-3.02M
EBT excluding unusual items
-2.78M
-6.32M
-4.18M
-3.02M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.79M
-3.28M
-4.18M
-3.02M
Net profit margin
-11,176.00%
-12,630.77%
-19,880.95%
-13,740.91%
Earnings per share
-3.68
-1.57
-0.44
-0.69
Interest and investment income
10.00K
11.00K
110.00K
8.00K
Interest expense
-149.00K
-148.00K
-391.00K
-
Net interest expenses
-139.00K
-137.00K
-281.00K
8.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.59M
-2.39M
-2.91M
-2.18M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer